Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT01721954
Registration number
NCT01721954
Ethics application status
Date submitted
26/10/2012
Date registered
6/11/2012
Date last updated
5/11/2019
Titles & IDs
Public title
FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer
Query!
Scientific title
Assessment of Overall Survival of FOLFOX6m Plus SIR-Spheres Microspheres Versus FOLFOX6m Alone as First-line Treatment in Patients With Non-resectable Liver Metastases From Primary Colorectal Carcinoma in a Randomised Clinical Study
Query!
Secondary ID [1]
0
0
STX0112
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
FOXFIREGlobal
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Colorectal Cancer Metastatic
0
0
Query!
Condition category
Condition code
Cancer
0
0
0
0
Query!
Bowel - Back passage (rectum) or large bowel (colon)
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - FOLFOX6m
Treatment: Devices - SIR-Spheres microspheres
Active Comparator: Control Arm - Systemic chemotherapy with FOLFOX6m plus or minus bevacizumab repeated every two weeks until evidence of treatment failure.
Experimental: Experimental Arm - Systemic chemotherapy with FOLFOX6m plus or minus bevacizumab plus SIR-Spheres microspheres.
Treatment: Drugs: FOLFOX6m
Treatment: Devices: SIR-Spheres microspheres
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Intervention code [2]
0
0
Treatment: Devices
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Overall Survival (OS)
Query!
Assessment method [1]
0
0
OS defined as the time interval between the date of randomization and the date of death from any cause.
Query!
Timepoint [1]
0
0
From date of randomization until the date of death from any cause assessed up 3 yrs 8 months
Query!
Secondary outcome [1]
0
0
Progression-free Survival
Query!
Assessment method [1]
0
0
PFS defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0), as an increase in the sum of the longest diameters of = 20% and an absolute increase in the sum of the longest diameters of = 5 mm, or the appearance of a new lesion.
Query!
Timepoint [1]
0
0
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 3 years 8 months.
Query!
Eligibility
Key inclusion criteria
- Age 18 years or older
- Willing and able to provide written informed consent
- Unequivocal and measurable CT evidence of liver metastases which are not treatable by
surgical resection or local ablation
- Limited extra-hepatic metastases in the lung and/or lymph nodes are permitted (Lung: 5
lesions total, < 1 cm, or 1 single lesion of up to 1.7 cm; Lymph nodules in one single
anatomic area (pelvis, abdomen or chest): any number, < 2 cm)
- All imaging evidence used as part of the screening process must be within 28 days
- Suitable for either treatment regimen
- WHO performance status 0-1
- Adequate hematological, renal and hepatic function
- Life expectancy of at least 3 months without any active treatment
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Evidence of ascites, cirrhosis, portal hypertension, main portal or venous involvement
or thrombosis as determined by clinical or radiologic assessment
- Previous radiotherapy delivered to the liver
- Non-malignant disease that would render the patient unsuitable for treatment according
to the protocol
- Peripheral neuropathy > grade 2 (NCI-CTC)
- Dose-limiting toxicity associated with previous adjuvant 5-FU or oxaliplatin
chemotherapy
- Prior non-adjuvant chemotherapy for any malignancy. Adjuvant chemotherapy for
colorectal cancer is permitted provided that it was completed more than 6 months
before entry into the study
- Pregnant or breast feeding
- Concurrent or prior history of cancer other than adequately treated non-melanoma skin
cancer or carcinoma in situ of the cervix
- Allergy to contrast media that would preclude angiography of the hepatic arteries
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/05/2013
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
28/02/2017
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
209
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,TAS,VIC,WA
Query!
Recruitment hospital [1]
0
0
Border Medical Oncology Research Unit - Albury
Query!
Recruitment hospital [2]
0
0
Gosford Hospital - Gosford
Query!
Recruitment hospital [3]
0
0
Southern Medical Day Care Centre - Wollongong
Query!
Recruitment hospital [4]
0
0
Royal Brisbane Hospital - Herston
Query!
Recruitment hospital [5]
0
0
Gold Coast Health Services District - Southport
Query!
Recruitment hospital [6]
0
0
Princess Alexandra Hospital - Woolloongabba
Query!
Recruitment hospital [7]
0
0
Royal Adelaide Hospital - Adelaide
Query!
Recruitment hospital [8]
0
0
Hobart Hospital - Hobart
Query!
Recruitment hospital [9]
0
0
Monash Medical Centre - Bentleigh East
Query!
Recruitment hospital [10]
0
0
Box Hill Hospital - Box Hill
Query!
Recruitment hospital [11]
0
0
Western Hospital - Footscray
Query!
Recruitment hospital [12]
0
0
Peninsula Oncology Centre - Frankston
Query!
Recruitment hospital [13]
0
0
South Eastern Hospital - Noble Park
Query!
Recruitment hospital [14]
0
0
Maroondah Hospital - Ringwood East
Query!
Recruitment hospital [15]
0
0
St. John of God Murdoch Hospital - Murdoch
Query!
Recruitment hospital [16]
0
0
Sir Charles Gairdner Hospital - Nedlands
Query!
Recruitment hospital [17]
0
0
Royal Perth Hospital - Perth
Query!
Recruitment postcode(s) [1]
0
0
2640 - Albury
Query!
Recruitment postcode(s) [2]
0
0
2250 - Gosford
Query!
Recruitment postcode(s) [3]
0
0
2500 - Wollongong
Query!
Recruitment postcode(s) [4]
0
0
4029 - Herston
Query!
Recruitment postcode(s) [5]
0
0
4215 - Southport
Query!
Recruitment postcode(s) [6]
0
0
4102 - Woolloongabba
Query!
Recruitment postcode(s) [7]
0
0
5000 - Adelaide
Query!
Recruitment postcode(s) [8]
0
0
7000 - Hobart
Query!
Recruitment postcode(s) [9]
0
0
3165 - Bentleigh East
Query!
Recruitment postcode(s) [10]
0
0
3128 - Box Hill
Query!
Recruitment postcode(s) [11]
0
0
3011 - Footscray
Query!
Recruitment postcode(s) [12]
0
0
3199 - Frankston
Query!
Recruitment postcode(s) [13]
0
0
3174 - Noble Park
Query!
Recruitment postcode(s) [14]
0
0
3135 - Ringwood East
Query!
Recruitment postcode(s) [15]
0
0
6150 - Murdoch
Query!
Recruitment postcode(s) [16]
0
0
6009 - Nedlands
Query!
Recruitment postcode(s) [17]
0
0
6000 - Perth
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
California
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Florida
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
Illinois
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
Louisiana
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Maryland
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
New York
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
North Carolina
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
Pennsylvania
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
South Carolina
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
Texas
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Utah
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Vermont
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
West Virginia
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
Wisconsin
Query!
Country [15]
0
0
Belgium
Query!
State/province [15]
0
0
Aalst
Query!
Country [16]
0
0
Belgium
Query!
State/province [16]
0
0
Brussels
Query!
Country [17]
0
0
Belgium
Query!
State/province [17]
0
0
Edegem
Query!
Country [18]
0
0
Belgium
Query!
State/province [18]
0
0
Gent
Query!
Country [19]
0
0
Belgium
Query!
State/province [19]
0
0
Liege
Query!
Country [20]
0
0
France
Query!
State/province [20]
0
0
Amiens Cedex 1
Query!
Country [21]
0
0
France
Query!
State/province [21]
0
0
Clichy Cedex
Query!
Country [22]
0
0
France
Query!
State/province [22]
0
0
Grenoble Cedex 9
Query!
Country [23]
0
0
France
Query!
State/province [23]
0
0
Paris
Query!
Country [24]
0
0
France
Query!
State/province [24]
0
0
Pessac
Query!
Country [25]
0
0
France
Query!
State/province [25]
0
0
Poitiers cedex
Query!
Country [26]
0
0
France
Query!
State/province [26]
0
0
Rennes Cedex
Query!
Country [27]
0
0
Germany
Query!
State/province [27]
0
0
Berlin
Query!
Country [28]
0
0
Germany
Query!
State/province [28]
0
0
Heilbronn
Query!
Country [29]
0
0
Germany
Query!
State/province [29]
0
0
Karlsruhe
Query!
Country [30]
0
0
Germany
Query!
State/province [30]
0
0
Magdeburg
Query!
Country [31]
0
0
Germany
Query!
State/province [31]
0
0
Marburg
Query!
Country [32]
0
0
Germany
Query!
State/province [32]
0
0
Muenster
Query!
Country [33]
0
0
Germany
Query!
State/province [33]
0
0
Munchen
Query!
Country [34]
0
0
Germany
Query!
State/province [34]
0
0
Munich
Query!
Country [35]
0
0
Israel
Query!
State/province [35]
0
0
Haifa
Query!
Country [36]
0
0
Israel
Query!
State/province [36]
0
0
Jerusalem
Query!
Country [37]
0
0
Israel
Query!
State/province [37]
0
0
Tel Aviv
Query!
Country [38]
0
0
Israel
Query!
State/province [38]
0
0
Tel Hashomer
Query!
Country [39]
0
0
Italy
Query!
State/province [39]
0
0
Aosta
Query!
Country [40]
0
0
Italy
Query!
State/province [40]
0
0
Bergamo
Query!
Country [41]
0
0
Italy
Query!
State/province [41]
0
0
Bologna
Query!
Country [42]
0
0
Italy
Query!
State/province [42]
0
0
Cuneo
Query!
Country [43]
0
0
Italy
Query!
State/province [43]
0
0
Pisa
Query!
Country [44]
0
0
Korea, Republic of
Query!
State/province [44]
0
0
Seoul
Query!
Country [45]
0
0
New Zealand
Query!
State/province [45]
0
0
Wellington
Query!
Country [46]
0
0
New Zealand
Query!
State/province [46]
0
0
Dunedin
Query!
Country [47]
0
0
New Zealand
Query!
State/province [47]
0
0
Grafton
Query!
Country [48]
0
0
New Zealand
Query!
State/province [48]
0
0
Palmerston North
Query!
Country [49]
0
0
Portugal
Query!
State/province [49]
0
0
Porto
Query!
Country [50]
0
0
Singapore
Query!
State/province [50]
0
0
Singapore
Query!
Country [51]
0
0
Spain
Query!
State/province [51]
0
0
Madrid
Query!
Country [52]
0
0
Spain
Query!
State/province [52]
0
0
Pamplona
Query!
Country [53]
0
0
Taiwan
Query!
State/province [53]
0
0
Taipei
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Query!
Name
Sirtex Medical
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This study is a randomized, multi-center study that will compare the efficacy and safety of
selective internal radiation therapy (SIRT) using SIR-Spheres microspheres plus a standard
chemotherapy regimen of FOLFOX6m versus FOLFOX6m alone as first-line therapy in patients with
non-resectable liver metastases from primary colorectal carcinoma.
Treatment with the biologic agent bevacizumab, if part of the standard of care at
participating institutions, is allowed within this study at the discretion of the
Investigator.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT01721954
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT01721954
Download to PDF